<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cipla Health welcomes FSSAI&#039;s new labelling rules for &#039;ORS&#039;, reinforces Prolyte ORS as the #AsliORS</title>
    <link>https://www.taxtmi.com/news?id=59634</link>
    <description>FSSAI requires removal of the term &#039;ORS&#039; from names, labels, and trademarks unless products meet the WHO approved composition of an Oral Rehydration Solution; Cipla Health welcomes this labelling restriction, states ProlyteORS is WHO approved and formulated to deliver the required electrolyte-glucose balance for therapeutic rehydration, and urges consumers to rely on clear labelling and credible certifications.</description>
    <language>en-us</language>
    <pubDate>Fri, 24 Oct 2025 13:46:02 +0530</pubDate>
    <lastBuildDate>Fri, 24 Oct 2025 13:46:02 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=859936" rel="self" type="application/rss+xml"/>
    <item>
      <title>Cipla Health welcomes FSSAI&#039;s new labelling rules for &#039;ORS&#039;, reinforces Prolyte ORS as the #AsliORS</title>
      <link>https://www.taxtmi.com/news?id=59634</link>
      <description>FSSAI requires removal of the term &#039;ORS&#039; from names, labels, and trademarks unless products meet the WHO approved composition of an Oral Rehydration Solution; Cipla Health welcomes this labelling restriction, states ProlyteORS is WHO approved and formulated to deliver the required electrolyte-glucose balance for therapeutic rehydration, and urges consumers to rely on clear labelling and credible certifications.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Fri, 24 Oct 2025 13:46:02 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=59634</guid>
    </item>
  </channel>
</rss>